Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Melanoma × Methods × Clear all

Sponsor

Conditions

Breast Neoplasms 5 Colorectal Neoplasms 4 Neoplasms 3 Head and Neck Neoplasms 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sleep Wake Disorders 1 Sleep Initiation and Maintenance Disorders 1 Prostatic Neoplasms 1 Prostate Adenocarcinoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Obesity 1 Multiple Myeloma 1 Mucositis 1 Motor Activity 1 Lymphoma 1 Lymphoid Interstitial Pneumonia 1 Lymphedema 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Diabetes Mellitus 1 Coronary Disease 1 Chronic Disease 1 Breast, Cervical or Colorectal Cancer Screening Needed 1 Bone Neoplasms 1 Body Weight Changes 1 Abnormalities, Radiation-Induced 1

Interventions

Ipilimumab 79 pembrolizumab 71 Nivolumab 68 aldesleukin 46 Cyclophosphamide 44 Interleukin-2 33 fludarabine phosphate 30 Vemurafenib 29 Dacarbazine 28 trametinib 25 fludarabine 25 dabrafenib 25 Temozolomide 21 Bevacizumab 15 Radiosurgery 14 Paclitaxel 12 Introns 12 Interferon alpha-2 12 binimetinib 11 Carboplatin 11 CTLA-4 Antigen 11 peginterferon alfa-2b 9 encorafenib 9 cobimetinib 9 Radiotherapy 9 talimogene laherparepvec 8 montanide ISA 51 8 atezolizumab 8 Sorafenib 8 spartalizumab 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡